These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 7200089)

  • 1. Transformation of rifamycin S into rifamycins B and L. A revision of the current biosynthetic hypothesis.
    Ghisalba O; Roos R; Schupp T; Nüesch J
    J Antibiot (Tokyo); 1982 Jan; 35(1):74-80. PubMed ID: 7200089
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ansamycin biogenesis: studies on a novel rifamycin isolated from a mutant strain of Nocardia mediterranei.
    White RJ; Martinelli E; Lancini G
    Proc Natl Acad Sci U S A; 1974 Aug; 71(8):3260-4. PubMed ID: 4528428
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Thiazorifamycins. III. Biosynthesis of rifamycins P, Q and verde, novel metabolites from a mutant of Nocardia mediterranea.
    Cricchio R; Antonini P; Sartori G
    J Antibiot (Tokyo); 1980 Aug; 33(8):842-6. PubMed ID: 7429988
    [TBL] [Abstract][Full Text] [Related]  

  • 4. New rifamycins produced by a recombinant strain of Nocardia mediterranei.
    Schupp T; Traxler P; Auden JA
    J Antibiot (Tokyo); 1981 Aug; 34(8):965-70. PubMed ID: 7319929
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Studies on rifamycin oxidase immobilized on kappa-carrageenan gel.
    Banerjee UC
    Biomater Artif Cells Immobilization Biotechnol; 1993; 21(5):665-74. PubMed ID: 8117856
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Isolation and characterization of 27-O-demethylrifamycin SV methyltransferase provides new insights into the post-PKS modification steps during the biosynthesis of the antitubercular drug rifamycin B by Amycolatopsis mediterranei S699.
    Xu J; Mahmud T; Floss HG
    Arch Biochem Biophys; 2003 Mar; 411(2):277-88. PubMed ID: 12623077
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of rifamycin oxidase immobilized on alginate gel.
    Banerjee UC
    Biomater Artif Cells Immobilization Biotechnol; 1993; 21(5):675-83. PubMed ID: 8117857
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rifamycin G, a further product of Nocardia mediterranei metabolism.
    Lancini G; Sartori G
    J Antibiot (Tokyo); 1976 Apr; 29(4):466-8. PubMed ID: 931815
    [No Abstract]   [Full Text] [Related]  

  • 9. [Phosphate control to rifamycin SV biosynthesis].
    Ni LY; Chiao JS
    Wei Sheng Wu Xue Bao; 1988 Dec; 28(4):340-5. PubMed ID: 3247718
    [No Abstract]   [Full Text] [Related]  

  • 10. A genetic approach to the biosynthesis of the rifamycin-chromophore in Nocardia mediterranei. II. Isolation and characterization of a shikimate excreting auxotrophic mutant of Nocardia mediterranei with normal rifamycin-production.
    Ghisalba O; Nüesch J
    J Antibiot (Tokyo); 1978 Mar; 31(3):215-25. PubMed ID: 649516
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A genetic approach to the biosynthesis of the rifamycin-chromophore in Nocardia mediterranei. I. Isolation and characterization of a pentose-excreting auxotrophic mutant of Nocardia mediterranei with drastically reduced rifamycin production.
    Ghisalba O; Nüesch J
    J Antibiot (Tokyo); 1978 Mar; 31(3):202-14. PubMed ID: 649515
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transformation of rifamycin B with growing and resting cells of Curvularia lunata.
    Banerjee UC
    Enzyme Microb Technol; 1993 Dec; 15(12):1037-41. PubMed ID: 7764294
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Effect of low molecular weight regulators on the biosynthesis of rifamycin B by Amycolatopsis mediterranei strains].
    Bushueva OA; Efremenkova OV; Gorin SE; Bartoshevich IuE
    Antibiot Khimioter; 1991 Mar; 36(3):11-5. PubMed ID: 1877868
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Deciphering the late steps of rifamycin biosynthesis.
    Qi F; Lei C; Li F; Zhang X; Wang J; Zhang W; Fan Z; Li W; Tang GL; Xiao Y; Zhao G; Li S
    Nat Commun; 2018 Jun; 9(1):2342. PubMed ID: 29904078
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Novel assay for screening rifamycin B-producing mutants.
    Vohra RM
    Appl Environ Microbiol; 1992 Jan; 58(1):403-4. PubMed ID: 1539986
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Quantitative analysis of mycelium morphological characteristics and rifamycin B production using Nocardia mediterranei.
    Lee KJ; Rho YT
    J Biotechnol; 1994 Aug; 36(3):239-45. PubMed ID: 7765266
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of B-factor and its analogues on rifamycin biosynthesis in Nocardia sp.
    Kawaguchi T; Azuma M; Horinouchi S; Beppu T
    J Antibiot (Tokyo); 1988 Mar; 41(3):360-5. PubMed ID: 3366694
    [TBL] [Abstract][Full Text] [Related]  

  • 18. New insights into rifamycin B biosynthesis: isolation of proansamycin B and 34a-deoxy-rifamycin W as early macrocyclic intermediates indicating two separated biosynthetic pathways.
    Stratmann A; Schupp T; Toupet C; Schilling W; Oberer L; Traber R
    J Antibiot (Tokyo); 2002 Apr; 55(4):396-406. PubMed ID: 12061548
    [TBL] [Abstract][Full Text] [Related]  

  • 19. B-factor, an essential regulatory substance inducing the production of rifamycin in a Nocardia sp.
    Kawaguchi T; Asahi T; Satoh T; Uozumi T; Beppu T
    J Antibiot (Tokyo); 1984 Dec; 37(12):1587-95. PubMed ID: 6526727
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rifamycin biosynthesis studied with 13C enriched precursors and carbon magnetic resonance.
    White RJ; Martinelli E; Gallo GG; Lancini G; Beynon P
    Nature; 1973 Jun; 243(5405):273-7. PubMed ID: 4743213
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.